Orally Administered Zn x Ce y O 2 /Se Hydrogel with Effective Antioxidant Activity for Treating Inflammatory Bowel Disease by Inhibiting Ferroptosis
Advanced Healthcare Materials · 2025-06 · 14 (15)
DOI: 10.1002/adhm.202500088 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 16.04.2025. Verfasst von Lingling Kan und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Engineering, Anhui Provincial Institute of Translational Medicine, Anhui Medical University, Hefei, 230032, P. R. China. Hauptthemen laut MEDLINE: Antioxidants, Inflammatory Bowel Diseases, Ferroptosis, Hydrogels. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: Natural Science Foundation of Anhui Province, National Natural Science Foundation of China, Natural Science Foundation of Anhui Provincial Department of Education.
Abstract (Originalsprache)
Oxidative stress leads to intestinal barrier damage, which induces immune responses to occur and further promotes oxidative stress exacerbating inflammatory bowel disease (IBD). In this work, the multifunctional Zn x Ce y O 2 /Se (ZCSO) nanozyme wrapped with acid‐resistant calcium alginate hydrogel designed for oral administration is prepared. The ZCSO nanozyme can promote the activation of the Nrf2 oxidative stress pathway, then significantly improve the efficiency of scavenging reactive oxygen species (ROS) and up‐regulate the protein expression of glutathione peroxidase 4 (GPx4), which is closely related to the inhibition of ferroptosis. In addition, the ZCSO nanozyme inhibiting the growth of some pathogenic bacteria proliferating due to oxidative stress shows a positive regulation of the intestinal flora and reduces the secretion of pro‐inflammatory factors and the levels of inflammatory macrophages, achieving the significant preventive and delayed therapeutic effect of colitis mice. Consequently, the distinctive properties of ZCSO nanozyme render it a promising candidate for the treatment of IBD by effectively scavenging ROS, thereby interrupting the detrimental cycle between oxidative stress and immune response, ultimately promoting the proliferation of epithelial cells to reestablish the integrity of the intestinal mucosal barrier.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biomedical Engineering, Anhui Provincial Institute of Translational Medicine, Anhui Medical University, Hefei, 230032, P. R. China.
- Anhui Engineering Research Center for Medical Micro-Nano Devices, Hefei, Anhui, 230012, P. R. China.
ORCID-Profile: Lingling Xu
Förderung
- Natural Science Foundation of Anhui Province
- National Natural Science Foundation of China
- Natural Science Foundation of Anhui Provincial Department of Education
Zitieren
APA
Kan, L., Li, T., Zhang, W., Zheng, Z., Zhang, G., Jin, Y., Wang, W., Qian, H., & Xu, L. (2025). Orally Administered Zn x Ce y O 2 /Se Hydrogel with Effective Antioxidant Activity for Treating Inflammatory Bowel Disease by Inhibiting Ferroptosis. Advanced Healthcare Materials, 14(15). https://doi.org/10.1002/adhm.202500088
Vancouver
Kan L, Li T, Zhang W, Zheng Z, Zhang G, Jin Y, et al. Orally Administered Zn x Ce y O 2 /Se Hydrogel with Effective Antioxidant Activity for Treating Inflammatory Bowel Disease by Inhibiting Ferroptosis. Advanced Healthcare Materials. 2025;14(15). doi:10.1002/adhm.202500088
BibTeX
@article{Kan2025,
author = {Kan, Lingling and Li, Tongsheng and Zhang, Weinan and Zheng, Ziwen and Zhang, Guoqiang and Jin, Yu and Wang, Wanni and Qian, Haisheng and Xu, Lingling},
title = {Orally Administered Zn x Ce y O 2 /Se Hydrogel with Effective Antioxidant Activity for Treating Inflammatory Bowel Disease by Inhibiting Ferroptosis},
journal = {Advanced Healthcare Materials},
year = {2025},
volume = {14},
number = {15},
doi = {10.1002/adhm.202500088}
}
EUVIMED